Q3 EPS Estimates for Henry Schein Lowered by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Zacks Research decreased their Q3 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research report issued on Thursday, October 17th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $1.35 per share for the quarter, down from their previous estimate of $1.36. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s FY2025 earnings at $5.19 EPS, Q3 2026 earnings at $1.39 EPS and FY2026 earnings at $5.67 EPS.

A number of other brokerages also recently commented on HSIC. UBS Group lowered their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. JPMorgan Chase & Co. lowered their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Barrington Research reiterated an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research report on Friday, September 20th. Finally, Robert W. Baird lowered their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Stock Up 1.0 %

Shares of HSIC opened at $72.39 on Friday. Henry Schein has a 52 week low of $60.01 and a 52 week high of $82.63. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $9.27 billion, a price-to-earnings ratio of 24.26, a PEG ratio of 1.98 and a beta of 0.86. The stock’s 50-day moving average price is $70.33 and its 200-day moving average price is $69.91.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. During the same quarter in the prior year, the business earned $1.31 earnings per share. The company’s revenue was up .0% compared to the same quarter last year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in HSIC. Summit Securities Group LLC purchased a new position in shares of Henry Schein during the second quarter worth $31,000. Beach Investment Counsel Inc. PA purchased a new position in shares of Henry Schein during the second quarter worth $37,000. Blue Trust Inc. boosted its position in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares during the period. Mather Group LLC. boosted its position in shares of Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after buying an additional 216 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after buying an additional 1,100 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.